| Members |
targetComponentId |
| Pseudomonas pseudoalcaligenes subsp konjaci |
Acidovorax konjaci |
| Pseudomonas pseudoflava |
Hydrogenophaga pseudoflava |
| Pseudomonas pseudomallei |
Burkholderia pseudomallei |
| Pseudomonas putrefaciens |
Shewanella putrefaciens |
| Pseudomonas pyrrocinia |
Burkholderia pyrrocinia |
| Pseudomonas radiora |
Methylobacterium radiotolerans |
| Pseudomonas rhodos |
Methylorubrum rhodinum (organism) |
| Pseudomonas rubrilineans |
Acidovorax avenae |
| Pseudomonas rubrisubalbicans |
Herbaspirillum rubrisubalbicans (organism) |
| Pseudomonas saccharophila |
Roseateles saccharophilus (organism) |
| Pseudomonas syringae ss savastoni |
Pseudomonas savastanoi |
| Pseudomonas syringae ss syringae |
Pseudomonas syringae |
| Pseudomonas syzygii |
Ralstonia syzygii (organism) |
| Pseudomonas taeniospiralis |
Hydrogenophaga taeniospiralis |
| Pseudomonas thomasii |
Ralstonia mannitolilytica (organism) |
| Pseudomonas vesicularis |
Brevundimonas vesicularis |
| Pseudomonas woodsii |
Robbsia andropogonis |
| erytem med feber som är resultatet av andra orsaker än Streptococcus pyogenes |
Rubeola scarlatinosa |
| Pseudozyma aphidids |
Moesziomyces bullatus (organism) |
| Psittacine papovavirus |
Budgerigar fledgling disease virus (organism) |
| psoriasis med artropati |
Psoriatic arthritis |
| Psoriatic arthropathy NOS |
Psoriatic arthritis |
| Psychalgia NOS |
Somatoform pain disorder |
| psykiatriker inom vård av personer med psykisk funktionsnedsättning |
Intellectual disability psychiatrist (occupation) |
| psykiatrisk vårdplan |
Psychiatry care plan (record artifact) |
| Psychic shock |
Acute stress disorder |
| Psychoactive substance abuse: [hypnotic (including non-dependent)] or [anxiolytic (including non-dependent)] or [barbiturate] or [sedative] or [tranquilliser] |
Psychoactive substance abuse |
| beroende av psykoaktiv substans med nuvarande användning |
Psychoactive substance dependence |
| Psychogenic genitourinary tract malfunction unspecified |
Psychogenic disorder of the genitourinary system |
| Psychogenic genitourinary tract symptom NOS |
Psychogenic disorder of the genitourinary system |
| psykogen impotens |
Erectile dysfunction due to psychophysiologic disorder (disorder) |
| Psychogenic impotence |
Erectile dysfunction due to psychophysiologic disorder (disorder) |
| psykogent hämmad manlig orgasm |
Inhibited male orgasm |
| Psychogenic pain unspecified |
Somatoform pain disorder |
| Psychogenic vomiting NOS |
Psychogenic vomiting |
| alkoholutlöst psykos |
Psychosis caused by ethanol (disorder) |
| Psychosocial deprivation |
Psychosocial deprivation |
| psykotisk beteende orsakat av intagbar alkohol |
Psychotic behaviour caused by ethanol |
| substansutlöst psykotisk störning |
Psychotic disorder |
| Psycnonotus jocusus emeria |
Pycnonotus jocosus (organism) |
| Pternistis afer afer |
Francolinus afer subspecies afer (organism) |
| somatisk dysfunktion i os pubis |
Somatic dysfunction of pubic region (finding) |
| Puerperal cerebrovascular disorder NOS |
Cerebrovascular disorder in the puerperium |
| Puerperal cerebrovascular disorder unspecified |
Cerebrovascular disorder in the puerperium |
| Puerperal fever |
Puerperal sepsis (disorder) |
| Puerperal infection (& [major]) |
Postnatal infection |
| Puerperal infection (& [major]) |
Postnatal infection |
| puerperal bäckeninfektion |
Puerperal sepsis (disorder) |
| Puerperal pyrexia NOS |
Puerperal pyrexia |
| Puerperal pyrexia NOS |
Puerperal pyrexia |
| Puerperal pyrexia of unknown origin unspecified |
Puerperal pyrexia of unknown origin |
| Puerperal: [major infection] or [sepsis] |
Postnatal infection |
| Pulmonary artery pressure monitoring by nursing personnel |
Pulmonary artery pressure monitoring |
| Pulmonary artery wedge pressure monitoring by nursing personnel |
Pulmonary artery wedge pressure monitoring |
| Pulmonary eosinophilia |
Pulmonary eosinophilia (disorder) |
| Pulmonary resection |
Lung excision |
| Pulmonary-aortic anastomosis |
Creation of shunt of descending aorta to pulmonary artery |
| Pulp capping |
Pulp cap, direct, excluding final restoration |
| Pulp gangrene |
Necrosis of the pulp |
| Punch biopsy of organ NEC |
Punch biopsy |
| Punctal plug |
Punctal plug (physical object) |
| punktion av cisterna magna |
Cisternal tap |
| Puncture of organ NOC |
Puncture procedure |
| Puncture of organ NOC NOS |
Puncture procedure |
| Pupil constriction |
Constricted pupil |
| Pupil dilation |
Dilated pupil |
| membrana pupillaris i vänster öga |
Pupillary membrane |
| membrana pupillaris i höger öga |
Pupillary membrane |
| Pur-In-Mix insulin adverse reaction |
Insulin adverse reaction |
| Pur-In-Mix insulin allergy |
Allergy to insulin |
| Purified protein derivative |
Product containing tuberculin purified protein derivative (medicinal product) |
| Purified protein derivative |
Product containing tuberculin purified protein derivative (medicinal product) |
| syfte med strålbehandling |
Radiation oncology AND/OR radiotherapy |
| Purpose of radiotherapy |
Radiation oncology AND/OR radiotherapy |
| Pustular |
Pustule |
| Putrescine |
Putrescine |
| trippelnjurbäcken |
Trifid pelvis of kidney |
| Pyemotes tritici |
Pyemotes ventricosus (organism) |
| antiinflammatoriskt medel med pyrazolderivat |
Pyrazole derivative |
| pyridostigminbromid 60 mg/5 ml, sirap |
Product containing precisely pyridostigmine bromide 12 milligram/1 milliliter conventional release oral solution (clinical drug) |
| pyridoxinberoendesyndrom |
Pyridoxine-dependent epilepsy (disorder) |
| pyridoxinpreparatallergi |
Allergy to pyridoxine (finding) |
| Pyrophosphotransferase |
Pyrophosphotransferase |
| Pyrrhura hypoxantha |
Pyrrhura molinae subspecies molinae (organism) |
| Pyrroline-5-carboxylate reductase deficiency |
Deficiency of pyrroline-5-carboxylate reductase |
| Q-T interval |
QT interval feature |
| Quadricoccus australiensis |
Quatrionicoccus australiensis (organism) |
| kinaprilallergi |
Non-allergic hypersensitivity to quinapril (finding) |
| Quinapril hydrochloride |
Product containing quinapril (medicinal product) |
| Quinidine gluconate 324mg |
Product containing only quinidine in oral dose form (medicinal product form) |
| kinidinglukonat 324 mg , tablett med modifierad frisättning |
Product containing only quinidine in oral dose form (medicinal product form) |
| kinidinglukonat 324 mg, depåtablett |
Product containing only quinidine in oral dose form (medicinal product form) |
| kinidinsulfat 300 mg, tablett med modifierad frisättning |
Product containing only quinidine in oral dose form (medicinal product form) |
| kinidinsulfat 300 mg, depåtablett |
Product containing only quinidine in oral dose form (medicinal product form) |
| kinindihydroklorid 300 mg/ml, infusionsvätska, lösning, ampull 1 ml |
Product containing precisely quinine dihydrochloride 300 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| kininhydroklorid 300 mg/ml, infusionsvätska, lösning, ampull 2 ml |
Quinine 300 mg/mL solution for injection |
| R1 phenotype |
CDe haplotype (finding) |
| R2 phenotype |
cDE haplotype (finding) |
| RBC color/staining NOS |
Red blood cell colour |
| RBC colour/staining NOS |
Red blood cell colour |
| RETIRED Concepts |
Inactive value (foundation metadata concept) |
FHIR